Blockade of PAF signaling could prevent synapse loss in the EAE hippocampus (Bellizzi et al., 2016) but also disrupts learning and memory (Jerusalinsky et al., 1994), and treatments targeting TNFα had deleterious effects in MS clinical trials (van Oosten et al., 1996). The gene discussed is TNF; the disease is myeloid sarcoma.